You are here: Industry Insights > CRISPR

News List

Using CRISPR to predict heart disease risk fiercebiotech
June 25, 2018
There are about 135 genes associated with cardiomyopathy and congenital heart conditions that can cause sudden death.
FDA halts CRISPR and Vertex’s upcoming gene editing trial biospectrumasia
June 04, 2018
The companies sought approval in April to begin the early-stage study in humans; it would be one of the first in the U.S. involving gene editing, a method of cutting out and replacing disease-causing snippets of DNA.
Feng Zhang and David Liu's base-editing CRISPR startup officially launches with $87M fiercebiotech
May 16, 2018
Feng Zhang's latest CRISPR company, Beam Therapeutics, officially came out of stealth Monday with $87 million in series A funding and a mission to develop "precision genetic medicines"
Jennifer Doudna's new CRISPR company will tackle disease detection fiercebiotech
April 28, 2018
Mammoth Biosciences unveiled itself Thursday, with technology licensed from the lab of Jennifer Doudna, Ph.D., and a mission to develop a CRISPR-based platform ...
CRISPR/Cas9 Gene Editing Market 2018 and Future Potential 2023 biospace
April 13, 2018
In 2018, more than 30 players participate in this market, from large multinational corporations to small, niche life sciences companies
What's next after CRISPR succeed in quest to transplant pig organs into humans? fiercebiotech
August 14, 2017
Transplanting animal organs into humans is an attractive approach, but the risk of immune rejection or catching a virus from the organ has been a significant roadblock. eGenesis used CRISPR to address the latter concern.
RNA-targeting CRISPR could yield treatments for Huntington's, ALS fiercebiotech
August 11, 2017
UC San Diego researchers are using CRISPR-Cas9 to target RNA, which could lead treatments for genetic diseases that have no cure.
MilliporeSigma Awarded its First CRISPR Patent by Australian Patent Office Posted americanpharmaceuticalreview
June 15, 2017
MilliporeSigma has announced that the Australian Patent Office has granted the company patent rights relating to the use of CRISPR in a genomic integration method for eukaryotic cells.
First CRISPR Patent for MilliporeSigma biospectrumasia
June 15, 2017
MilliporeSigma has patent filings for its insertion CRISPR method in Brazil, Canada, China, Europe, India, Israel, Japan, Singapore, South Korea, and the U.S.
MilliporeSigma Develops New CRISPR Genome Editing Method contractpharma
May 26, 2017
Aims to provide researchers with more experimental options and faster results

Previous page 1 2 3 4 5 6 7 8 Next page